Back to search

Article

A Single Institution Experience of Bortezomib for GVHD in a Pediatric HSCT Population

2024-01-31

Abstract excerpt

Acute graft versus host disease (aGvHD) remains one of the most serious complications, occurring in about 30-70%, of allogeneic hematopoietic stem cell transplantation (HSCT) recipients. While about 40-60% of these recipients will respond to steroids as first line, there is no consensus on second line agents. The management of steroid-refractory (SR) and steroid dependent (SD) GVHD after HSCT continues to be chall...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4028153c-62ed-55ef-b2fa-a64371e1cbaa
DOI
10.22541/au.170668419.92045549/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Single Institution Experience of Bortezomib for GVHD in a Pediatric HSCT PopulationDOI 10.22541/au.170668419.92045549/v1
Select a neighboring publication to make it the new centre.